ISSN: 1527-2729

Journal Guideline

Current Treatment Options in Oncology Q1 Unclaimed

Springer New York United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Treatment Options in Oncology offers in-depth review articles contributed by international experts on the most significant developments in the field. By providing clear, insightful, balanced review articles that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the treatment of cancer. It has an SJR impact factor of 1,326.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Oncology (Q1) Pharmacology (medical) (Q1)

Price

3190 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,326

SJR Impact factor

66

H Index

115

Total Docs (Last Year)

332

Total Docs (3 years)

8845

Total Refs

1403

Total Cites (3 years)

327

Citable Docs (3 years)

3.91

Cites/Doc (2 years)

76.91

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Cancer Q1
Journal of Thoracic Oncology Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1

Compare this journals

Aims and Scope

Best articles by citations

Ovarian Cancer Cytoreductive Surgery in the Elderly

Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration

Treatment of Elderly Acute Myeloid Leukemia Patients

Maintaining Fertility in Young Women with Breast Cancer

Evolution of Robotic Surgery in the Treatment of Localized Prostate Cancer

Brain metastases

Molecular Predictors of Radiotherapy Response in Sarcoma

Basic Assessment of the Older Cancer Patient

Sequencing of ALK Inhibitors in ALK+ Non-Small Cell Lung Cancer

Management of bone metastases in breast cancer

Treating Prostate Cancer in Elderly Men: How Does Aging Affect the Outcome?

The Role of Allogeneic Stem Cell Transplantation in Hodgkin's Lymphoma

SHOW MORE ARTICLES

Sequencing Systemic Therapies for Metastatic Kidney Cancer

Targeted therapies for gynecologic malignancies

Exercise Therapy in the Management of Solid Tumors

Phytochemicals in the Oncology Setting

Recent Advances in Oncology Acupuncture and Safety Considerations in Practice

Emerging Role of Genomics and Cell-Free DNA in Breast Cancer

The Role of Targeted Agents in the Treatment of Elderly Patients with Non-Small Cell Lung Cancer (NSCLC)

Targeted Therapy in Biliary Tract Cancers

Imatinib mesylate and its potential implications for gynecologic cancers

Advancing Immunotherapy in Metastatic Breast Cancer

Quality Assurance and Improvement in Head and Neck Cancer Surgery: From Clinical Trials to National Healthcare Initiatives

Treatment of Glioblastoma in "Elderly" Patients